MetaVia to Present Data Highlighting DA-1726, a GLP-1/Glucagon Dual Agonist, in a Late-Breaking Poster Presentation at the EASL Congress 2026

Go back to MetaVia to Present Data Highlighting DA-1726, a GLP-1/Glucagon Dual Agonist, in a Late-Breaking Poster Presentation at the EASL Congress 2026
(NASDAQ: MTVA) Delayed: 1.60 --0 (-0%)
Previous Close $1.60    52 Week High
Open $1.60    52 Week Low
Day High $1.60    P/E N/A 
Day Low $1.60    EPS
Volume 2,523